AXGN
Axogen, Inc.Company with tickers: AXGN
CIK
805928
CUSIP
05463X106
Shares Outstanding
53,177,824
13F Activity (30d)
9 filings
7 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $61,457,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | $46,189,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Operating Expenses | — | ||||
| Research & Development | $7,517,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Operating Income | $-2,832,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| Net Income | $-19,584,000 | USD | 2026-03-31 | 10-Q | 2026-04-28 |
| EPS (Basic) | $-0.38 | USD/shares | 2026-03-31 | 10-Q | 2026-04-28 |
| EPS (Diluted) | $-0.38 | USD/shares | 2026-03-31 | 10-Q | 2026-04-28 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Geography (USD)
| Component | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| United States | $156,214,000 | $184,249,000 | $222,435,000 |
| Non Us | $2,798,000 | $3,089,000 | $2,773,000 |